Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Convio, Inc. (CNVO)
|
Add to portfolio |
|
|
Price: |
$16.07
| | Metrics |
OS: |
18.9
|
M
| |
|
|
Market cap: |
$304
|
M
| |
26
|
% ROIC
|
Net cash:
|
$51.9
|
M
| |
$2.74
|
per share
|
EV:
|
$252
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$7.5
|
M
| |
33.5
|
x EV/EBITDA
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
Revenues | 80.4 | 69.7 | 63.1 | 57.0 | 43.1 | 21.5 | 13.3 | 9.0 |
Revenue growth | 15.2% | 10.6% | 10.7% | 32.3% | 100.8% | 61.9% | 47.4% | |
Cost of goods sold | 31.1 | 25.5 | 24.8 | 22.9 | 18.7 | 7.9 | 5.0 | 3.3 |
Gross profit | 49.2 | 44.2 | 38.3 | 34.1 | 24.4 | 13.5 | 8.2 | 5.7 |
Gross margin | 61.2% | 63.4% | 60.7% | 59.8% | 56.6% | 63.0% | 62.2% | 63.6% |
Sales and marketing | 25.4 | 22.5 | 21.6 | 21.4 | 19.4 | 12.2 | 9.6 | 8.6 |
Research and development | 10.7 | 10.6 | 10.0 | 8.8 | 7.2 | 3.5 | 2.6 | 2.1 |
General and administrative | 9.3 | 6.6 | 6.0 | 5.9 | 4.5 | 2.4 | 1.9 | 1.3 |
EBITA | 4.4 | 4.8 | 1.7 | -2.5 | -5.8 | -4.5 | -5.9 | -6.3 |
EBITA margin | 5.5% | 6.8% | 2.7% | -4.4% | -13.5% | -20.9% | -44.3% | -69.8% |
Amortization of intangibles | 1.6 | 1.0 | 2.4 | 2.5 | 2.2 | | | |
EBIT | 2.8 | 3.8 | -0.7 | -5.0 | -8.0 | -4.5 | -5.9 | -6.3 |
EBIT margin | 3.5% | 5.4% | -1.1% | -8.7% | -18.5% | -20.9% | -44.3% | -69.8% |
Pre-tax income | 2.9 | 3.8 | -1.9 | -3.7 | -10.5 | -5.0 | -5.8 | -6.3 |
Income taxes | -12.0 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | 8.0% | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | 14.9 | 3.0 | -2.1 | -3.7 | -10.5 | -5.0 | -5.8 | -6.3 |
Net margin | 18.5% | 4.4% | -3.3% | -6.6% | -24.4% | -23.2% | -43.7% | -69.9% |
|
Diluted EPS | $0.76 | $0.17 | ($0.29) | ($0.52) | ($1.68) | ($2,705.98) | ($6,104.32) | ($6.75) |
Shares outstanding (diluted) | 19.5 | 17.5 | 7.3 | 7.3 | 6.3 | 0.0 | 0.0 | 0.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|